October 16, 2019
Sun Pharma Launches Drizalma Sprinkle in the U.S.
Sun pharma has launched the first and only FDA-approved sprinkle formulation of delayed-release duloxetine capsules, which is, as the company…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Regions
October 15, 2019
Aura Biosciences candidate AU-011 could be first FDA approved therapy for primary treatment chorodial melanoma
Aura Biosciences said in a presentation at American Academy od Ophtalmology that its lead product candidate light-activated AU-011 has the potential to be the first FDA approved therapy for the primary treatment of choroidal melanoma.
October 15, 2019
U.S. FDA approves Secuado transdermal system, the first-and-only transdermal patch for the treatment of adults with schizophrenia
MIAMI & JERSEY CITY, N.J.–(BUSINESS WIRE)–Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced the U.S.…
October 15, 2019
Azitra Completes $14 Million Series A Financing
FARMINGTON, Conn.–(BUSINESS WIRE)–Azitra Inc., a clinical-stage medical dermatology company addressing serious skin conditions by harnessing the microbiome, today announced that…
October 15, 2019
Ligand Appoints Pharmaceutical Executive Sarah Boyce to its Board of Directors
SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) (“Ligand” or “the Company”) announces the appointment of Sarah Boyce to the Company’s…
October 15, 2019
CEL-SCI Reports Recent Data Review by the Independent Data Monitoring Committee for Its Pivotal Phase 3 Head and Neck Cancer Study
VIENNA, Va.–(BUSINESS WIRE)–CEL-SCI Corporation (NYSE American: CVM) announced today that the Independent Data Monitoring Committee (IDMC) for the Company’s pivotal…
October 15, 2019
Trialbee and TriNetX Partner to Accelerate Patient-Centric Clinical Trials
MALMÖ, Sweden & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Trialbee, a world-leading technology provider in patient matching and engagement, is partnering with…
October 15, 2019
Numab Appoints Daniel Vasella to Board of Directors
PFÄFFIKON, Switzerland–(BUSINESS WIRE)–Numab Therapeutics AG today announced that effective October 1 it has appointed former Novartis CEO and Chairman Dr.…
October 15, 2019
Checkmate Pharmaceuticals Announces Additions to Management Team
Checkmate Pharmaceuticals has added experienced industry executives to lead clinical research and regulatory affairs with the appointments of James Wooldridge,…
October 15, 2019
Takeda sheds select OTC and non-core assets to Acino for over $200 M
Takeda said Tuesday it will sell certain OTC and non-core assets for over $200 million to ACino, to accelerate deleveraging as it said it will simplify portfolio in Takeda’s NEMEA region.